<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>malaria prevention innovation &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/malaria-prevention-innovation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 03 Jun 2025 13:58:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>malaria prevention innovation &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Sanaria Announces Promising Early Safety Outcomes for Innovative PfSPZ-LARC2 Malaria Vaccine</title>
		<link>https://bioengineer.org/sanaria-announces-promising-early-safety-outcomes-for-innovative-pfspz-larc2-malaria-vaccine/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 03 Jun 2025 13:58:36 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Burkina Faso clinical trials]]></category>
		<category><![CDATA[genetically attenuated parasites]]></category>
		<category><![CDATA[malaria prevention innovation]]></category>
		<category><![CDATA[malaria vaccine safety]]></category>
		<category><![CDATA[PfSPZ-LARC2 vaccine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/sanaria-announces-promising-early-safety-outcomes-for-innovative-pfspz-larc2-malaria-vaccine/</guid>

					<description><![CDATA[In an inspiring leap forward in the global effort to conquer malaria, researchers at the Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have announced a pivotal milestone in the clinical development of the Sanaria® PfSPZ-LARC2 Vaccine. This vaccine, engineered to prevent infection by the deadly Plasmodium falciparum parasite, has successfully passed its [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">248069</post-id>	</item>
	</channel>
</rss>
